Dr Nandini Verma

vidwan id: 171417

Female

Scientific Officer E, Cancer Research Institute
Advanced Centre for Treatment, Research and Education in Cancer

23571047100

Expertise

Biochemistry and Molecular Biology

Publications

Total Articles 17

Books 0

Proceedings 0

Publications

Scopus

Citations 493

h-index 12

CrossRef

Citations 537

h-index 11

Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Bio

Breast Cancer Research

Personal Details

Female
Scientific Officer E , Advanced Centre for Treatment, Research and Education in Cancer
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Plot No. 1& 2, Kharghar

Ph.D

Other Institute 2012

Scientific Officer E Jul 2019 – Present

Advanced Centre for Treatment, Research and Education in Cancer | Cancer Research Institute

Related Profiles

Experts (1229+)

View All

Assistant Professor

Assistant Professor

Assistant Professor

Physical Director

Assistant Professor

Assistant Professor

Dr Jyothi Alias Jyotsna Baragi

Assistant Professor

Ms Shalini Saini

Assistant Professor

Prof Annette M Bhambal

Professor

SHIVANI SHARMA

N/A

Organisations (107+)

View All

Dr Atul Budukh

Professor

Dr Ashok Varma

Principal Investigator

Dr Atanu Bhattacharjee

Assistant Professor

Associate Professor

Scientific Officer C

Associate Professor

Scientific Officer D

Scientific Officer C

Professor

Associate Professor

Co-Authors (12)

Prof Rina Chakrabarti

N/A

Prof Manisha Goel

University of Delhi

Dr Hemant Gautam

CSIR-Institute of Genomics and Integrative Biology

Prof Manoj Pandey

Banaras Hindu University

Prof Pardha Saradhi P

University of Delhi

Dr Poonam Gera

Advanced Centre for Treatment, Research and Education in Cancer

Dr Rahul Thorat

Advanced Centre for Treatment, Research and Education in Cancer

Prof Rajinder K Gupta

Delhi Technological University

Dr Sorab Dalal

Advanced Centre for Treatment, Research and Education in Cancer

Prof Jai Gopal Sharma

Delhi Technological University

Dr Siddhesh Kamat

Indian Institute of Science Education and Research(IISER), Pune

Prof Surinder Jaswal

Tata Institute of Social Sciences

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer

Open Access

Article

Redox Biology. Year: 2025. Volume: 79 .

Authors: Jog E.;Jainarayanan A.K.;La Ferlita A.;Chakraborty A.;Dalwai A.;Yahya S.;Shivashankar A.;Choudhary B.S.;Chandramouli A.;Kazi M.;Jain D.;Khapare N.;B A.;Khan B.K.;Gera P.;Patil P.;Thorat R.;Verma N.;Sehgal L.;Saklani A.;Kamat S.S.;Dalal S.N.;Chaudhary N.

10.1016/j.redox.2024.103458

Symposium report: breast cancer in India—trends, environmental exposures and clinical implications

Open Access

Review

Year: 2021. Volume: 32 , Issue: 6 , Pages: 567-575 .

Authors: McDonald J.A.;Rao R.;Gibbons M.;Janardhanan R.;Jaswal S.;Mehrotra R.;Pandey M.;Radhakrishnan V.;Ramakant P.;Verma N.;Terry M.B.

10.1007/s10552-021-01428-y

Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis

Open Access

Article

Science Advances. Year: 2020. Volume: 6 , Issue: 34 .

Authors: Verma N.;Vinik Y.;Saroha A.;Nair N.U.;Ruppin E.;Mills G.;Karn T.;Dubey V.;Khera L.;Raj H.;Maina F.;Lev S.

10.1126/sciadv.aba8968

124

Correction: Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4–NDRG1 axis (Cancer Research (2017) 77 (86–99) DOI: 10.1158/0008-5472.CAN-16-1797)

Open Access

Erratum

Year: 2020. Volume: 80 , Issue: 2 , Pages: 362 .

Authors: Verma N.;Muller A.K.;Kothari C.;Panayotopoulou E.;Kedan A.;Selitrennik M.;Mills G.B.;Nguyen L.K.;Shin S.;Karn T.;Holtrich U.;Lev S.

10.1158/0008-5472.CAN-19-3573

HER family in cancer progression: From discovery to 2020 and beyond

Open Access

Book Chapter

Advances in Cancer Research. Year: 2020. Volume: 147 , Pages: 109-160 .

Authors: Kumar R.;George B.;Campbell M.R.;Verma N.;Paul A.M.;Melo-Alvim C.;Ribeiro L.;Pillai M.R.;da Costa L.M.;Moasser M.M.

10.1016/bs.acr.2020.04.001

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

Open Access

Article

Year: 2018. Volume: 9 , Issue: 10 .

Authors: Kedan A.;Verma N.;Saroha A.;Shreberk-Shaked M.;Müller A.K.;Nair N.U.;Lev S.

10.1038/s41419-018-1005-z

Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer

Open Access

Article

PLOS Computational Biology. Year: 2018. Volume: 14 , Issue: 6 .

Authors: Shin S.Y.;Müller A.K.;Verma N.;Lev S.;Nguyen L.K.

10.1371/journal.pcbi.1006192

Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4-NDRG1 axis

Open Access

Article

Year: 2017. Volume: 77 , Issue: 1 , Pages: 86-99 .

Authors: Verma N.;Müller A.K.;Kothari C.;Panayotopoulou E.;Kedan A.;Selitrennik M.;Mills G.B.;Nguyen L.K.;Shin S.;Karn T.;Holtrich U.;Lev S.

10.1158/0008-5472.CAN-16-1797

« Previous
Next »

Showing 1 to 8 of 17 results